BMS' debut DTC campaign for psoriasis drug Sotyktu includes a TV ad, which ran on the Grammys, showing confident patients.

February 6, 2023 03:28 PM ESTUpdated 05:48 PM

Marketing

Bristol Myers debuts first psoriasis drug ad on Grammys, leading chorus of pharma brands

Beth Snyder Bulik

Senior Editor

Bristol Myers Squibb debuted its psoriasis med on one of the few remaining big mainstream TV stages on Sunday night. Its first direct-to-consumer campaign for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bristol Myers debuts first psoriasis drug ad on Grammys, leading chorus of pharma brands

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Patient dies in Neurogene's Rett syndrome study

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Halozyme withdraws Evotec acquisition proposal after biotech is 'unwilling to engage'

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

Are programs with compounded GLP-1s safe for your population?

Bris­tol My­ers de­buts first pso­ri­a­sis drug ad on Gram­mys, lead­ing cho­rus of phar­ma brands

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

Bristol Myers debuts first psoriasis drug ad on Grammys, leading chorus of pharma brands

Patient dies in Neurogene's Rett syndrome study

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Halozyme withdraws Evotec acquisition proposal after biotech is 'unwilling to engage'

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

Are programs with compounded GLP-1s safe for your population?